[go: up one dir, main page]

Groth, 1980 - Google Patents

2.7. Methods and approaches to determine “optimal” quality for clinical chemical data

Groth, 1980

Document ID
4559997922392767013
Author
Groth T
Publication year
Publication venue
Scandinavian Journal of Clinical and Laboratory Investigation

External Links

Snippet

“There is no simple over-all answer, and any answer that we find will be temporary, depending on the progress of medical knowledge and technology”. RN Barnett 1968 [4] Although clinical reasoning and decision-making may be very complex, there are methods …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q40/00—Finance; Insurance; Tax strategies; Processing of corporate or income taxes

Similar Documents

Publication Publication Date Title
US6099469A (en) Reflex algorithm for early and cost effective diagnosis of myocardial infractions suitable for automated diagnostic platforms
Martínez-Arranz et al. Enhancing metabolomics research through data mining
Panteghini et al. Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference
Henny et al. Need for revisiting the concept of reference values
US11885733B2 (en) White blood cell population dynamics
Groth 2.7. Methods and approaches to determine “optimal” quality for clinical chemical data
CN115862838A (en) A machine learning algorithm-based diagnostic model for cholangiocarcinoma and its construction method and application
US20130218581A1 (en) Stratifying patient populations through characterization of disease-driving signaling
Groth et al. Optimal screening for patients with hyperparathyroidism with use of serum calcium observations. A decision-theoretical analysis
Weitz Nostradamus A knowledge-based forecasting advisor
Burke et al. Clinical validation of molecular biomarkers in translational medicine
Berson et al. Cross-species comparative analysis of single presynapses
Infantino et al. Harmonization of anti-nuclear antibody testing (ANA) by indirect immunofluorescence assay: results from ten years of UK NEQAS external quality assessment
US20050079099A1 (en) Generation of biochemical images and methods of use
Groth et al. 4.5. Diagnosis, size estimation and prediction of acute myocardial infarction from S-myoglobin observations. A system analysis to assess the influence of various sources of variability
EP0962186B1 (en) Automated diagnostic system implementing immunoassays and clinical chemistry assays according to a reflex algorithm
Varghese et al. Identification of diagnostic urinary biomarkers for acute kidney injury
Jensen et al. Application of Receiver-Operating-Characteristic (ROC) Curves to veterinary clinical pathology
US5398187A (en) Correlation detection method and connectivity-structure estimation method for neurons
Melus et al. Biomarker and data science as integral part of precision medicine
Li et al. Unraveling the predictors of enlarged perivascular spaces: a comprehensive logistic regression approach in cerebral small vessel disease
Ciptawaty et al. Causal Modelling of Economic Growth: A Review of Four Key Variables Using SAS
Vogt et al. Cluster-oriented discriminant analysis; taxonomic classification of the thyroid function
Albert et al. On the interpretation of serial laboratory measurements in acute myocardial infarction.
CN119479803A (en) Data mining analysis method and system for thyroid stimulating hormone receptor antibody response